498 . Cite . What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? Petrini P. Petrini P. . Cite . Item in Clipboard 526 . Cancer Sci. 2021 Sep 10. doi: 10.1111/cas.15131. Online ahead of print. Cancer Sci. 2021. PMID: 34506683 Free article. . Item in Clipboard
526 . Cancer Sci. 2021 Sep 10. doi: 10.1111/cas.15131. Online ahead of print. Cancer Sci. 2021. PMID: 34506683 Free article. . Item in Clipboard